RecruitingAnal Cancer
Self-sampling to Optimize Anal Lesion Outcomes
Eligible age
35+ yrs
Accepts
All genders
Locations
3 states
Healthy volunteers
Yes
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The purpose of this research study is to find ways to increase anal cancer screening among people at increased risk for anal cancer. This study will try to find out if persons will do an intervention (self-sampling of the anal canal) and if it affects cytology and high-resolution anoscopy (HRA) appointment attendance. Secondarily, the study will assess if a person who gets their choice of either self-sampling or healthcare provider sampling affects clinic attendance.
Sponsor: Medical College of Wisconsin
You may qualify if…
- ✓ 1. Age ≥ 35 years for those who are HIV-positive or ≥ 45 years for those who are HIV-negative.
- ✓ 2. Must be either:
- ✓ 1. A cisgender or transgender sexual minority man, or
- ✓ 2. A transgender woman who has sex with men.
- ✓ 3. Resides in Chicago, Houston, or Milwaukee metropolitan area.
- ✓ 4. Is willing to attend a study clinic.
- ✓ 5. Speak and understand either English or Spanish
- ✓ 6. Ability to understand a written informed consent document, and the willingness to sign it.
You may not qualify if…
- ✕ A potential study subject who meets any of the following exclusion criteria is ineligible to participate in the study.
- ✕ 1. Was a participant in the PAC Self-Swab Study in Milwaukee.
- ✕ 2. Currently on anticoagulants, with the exception of aspirin or non-steroidal anti-inflammatory drugs (NSAIDs), e.g., ibuprofen, naproxen.
- ✕ 3. Diagnosed with hemophilia, cirrhosis with bleeding varices, or thrombocytopenia.
- ✕ 4. Presence of any contraindicating severe disease or condition, e.g., anal stenosis.
- ✕ 5. Plans to move within 12 months after enrollment.
Where it's recruiting
Source: ClinicalTrials.gov · NCT07192055 · last updated 2026-05-12